-
-
Population-based ovarian cancer screening programs have been difficult to recommend and implement because poor sensitivity and positive predictive value characteristics accompany expensive and inefficient testing methodology and triage algorithms.
-
Ogburn and colleagues report on their experience with adnexal torsion at one university medical center from 1990 to 2001. A chart review identified 68 patients in whom laparoscopic management was accomplished 32% of the time (n = 22) and ovarian conservation in 21% (n = 14).
-
A new combination hormone product has been approved for the treatment of menopausal symptoms. Drospirenone (DRSP), a progestin with mineralo-corticoid activity, is combined with estradiol (E2). DRSP is the same progestin found in the popular oral contraceptive, Yasmin®. DRSP-E2 is marketed by Berlex as Angeliq®.
-
Endometrial cancer is the most common gynecologic malignancy and is usually characterized by limited disease at presentation. Among the number of known prognostic factors, grade of disease is one frequently used to triage patients for formal surgical staging.
-
Souka and colleagues have recently published a review that should be very helpful to the clinician confronted with the dilemma of counseling patients whose fetuses have increased nuchal translucencies (NTs) in the first trimester.
-
Erectile Dysfunction and Visual Disturbance; Mixed News on Statins; FDA Actions
-
A study that attracted some attention at the Society for Maternal-Fetal Medicine meeting last year was recently published in the American Journal of Obstetrics and Gynecology. It dealt with the usefulness of fetal fibronectin (fFN) and cervical length (CL) in predicting which patients with preterm contractions (PTC) were truly in preterm labor (PTL).
-
Epidemiologists at the National Cancer Institute organized and conducted a retrospective cohort study, recruiting patients treated between 1965 and 1988 from endocrine and infertility practices in 5 academic centers.
-
